How High Drug Prices and Big Lobbying Budgets Go Together for Big Pharma

May 1, 2018

Another pharmaceutical giant’s rising insulin prices, means bad news for consumers. In this article from Fortune and Kasier Health News, the journalists shed light on how lobbying impacts the prescription drug world from a cost perspective. Connecture data used. Read the full article here.